clofibrate and alfibrate

clofibrate has been researched along with alfibrate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ho, LT; Lam, HC; Li, SH; Tang, KT; Wang, JT1
Hartmann, G; Stähelin, HB1
Azanza Perea, JR; Honorato Pérez, J1
Bruseghini, L; Dalmau, J; Vicens, B; Zapatero, J1

Trials

3 trial(s) available for clofibrate and alfibrate

ArticleYear
The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
    Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1987, Volume: 40, Issue:5

    Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Diabetes Complications; Double-Blind Method; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged

1987
[Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1974, Jun-28, Volume: 99, Issue:26

    Topics: Adult; Aged; Aluminum; Cholesterol; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Drug Evaluation; Drug Tolerance; Female; Humans; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Phospholipids; Time Factors; Triglycerides

1974
Plafibride tolerance trial at increasing doses in healthy volunteers.
    Arzneimittel-Forschung, 1981, Volume: 31, Issue:10a

    Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Blood Cell Count; Blood Glucose; Clofibrate; Clofibric Acid; Double-Blind Method; Hemodynamics; Humans; Hypolipidemic Agents

1981

Other Studies

1 other study(ies) available for clofibrate and alfibrate

ArticleYear
[Single-blind study of the efficacy of pirozadil versus alufibrate in the treatment of primary hyperlipoproteinemias].
    Revista de medicina de la Universidad de Navarra, 1982, Volume: 26, Issue:1

    Topics: Cholesterol; Clofibrate; Clofibric Acid; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Pyridines; Random Allocation

1982